Drug shortage
Dexmedetomidine Hydrochloride Injection · Jiangsu Hengrui Pharmaceuticals Co., Ltd.
FDA drug shortage · Current · updated Apr 6, 2026
Key facts
| Generic name | Dexmedetomidine Hydrochloride Injection |
|---|---|
| Company | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) |
| Dosage form | Injection |
| Status | Current |
| Therapeutic category | Anesthesia |
| Package NDCs | 83634-600-02 |
| First posted | Apr 10, 2020 |
| Last updated | Apr 6, 2026 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: